Single-Center Experience of Pediatric Heart Transplantation in Taiwan

N. K. Chou, C. H. Chang, N. H. Chi, C. I. Chang, Y. S. Chen, E. T. Wu, M. H. Wu, J. K. Wang, R. B. Hsu, S. C. Huang, W. J. Ko, S. H. Chu, F. Y. Lin, S. S. Wang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Heart transplantation (HTx) is a treatment for end-stage heart failure or a complex or inoperable congenital defect. The long-term survival and the adequate donor to recipient body weight (D/R BW) ratio remain to be determined. From March 1995 to May 2004, 14 children (6 months-16 years of age) underwent HTx due to underlying diseases of idiopathic dilated cardiomyopathy (n = 10; 71.4%), congenital heart disease (n = 3; 21.4%), and Kawasaki disease (n = 1; 7.1%). Donor-recipient body weight ratio ranged from 0.89 to 3.9. Big heart syndrome was present in one patient when D/R BW ratio was more than 3. Actuarial survival was 92.9% at 5 years after transplantation. Only the one patient who had Kawasaki disease died due to early primary graft failure. HTx is a feasible method with good long-term survival rates for end-stage heart failure or for complex or inoperable congenital defects. After careful pretransplant evaluation, a high D/R BW ratio (more than 3) is acceptable.

Original languageEnglish
Pages (from-to)2130-2131
Number of pages2
JournalTransplantation Proceedings
Volume38
Issue number7
DOIs
Publication statusPublished - Sep 2006
Externally publishedYes

Fingerprint

Heart Transplantation
Taiwan
Body Weight
Tissue Donors
Pediatrics
Mucocutaneous Lymph Node Syndrome
Heart Failure
Survival
Dilated Cardiomyopathy
Heart Diseases
Survival Rate
Transplantation
Transplants
Therapeutics

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Chou, N. K., Chang, C. H., Chi, N. H., Chang, C. I., Chen, Y. S., Wu, E. T., ... Wang, S. S. (2006). Single-Center Experience of Pediatric Heart Transplantation in Taiwan. Transplantation Proceedings, 38(7), 2130-2131. https://doi.org/10.1016/j.transproceed.2006.07.020

Single-Center Experience of Pediatric Heart Transplantation in Taiwan. / Chou, N. K.; Chang, C. H.; Chi, N. H.; Chang, C. I.; Chen, Y. S.; Wu, E. T.; Wu, M. H.; Wang, J. K.; Hsu, R. B.; Huang, S. C.; Ko, W. J.; Chu, S. H.; Lin, F. Y.; Wang, S. S.

In: Transplantation Proceedings, Vol. 38, No. 7, 09.2006, p. 2130-2131.

Research output: Contribution to journalArticle

Chou, NK, Chang, CH, Chi, NH, Chang, CI, Chen, YS, Wu, ET, Wu, MH, Wang, JK, Hsu, RB, Huang, SC, Ko, WJ, Chu, SH, Lin, FY & Wang, SS 2006, 'Single-Center Experience of Pediatric Heart Transplantation in Taiwan', Transplantation Proceedings, vol. 38, no. 7, pp. 2130-2131. https://doi.org/10.1016/j.transproceed.2006.07.020
Chou, N. K. ; Chang, C. H. ; Chi, N. H. ; Chang, C. I. ; Chen, Y. S. ; Wu, E. T. ; Wu, M. H. ; Wang, J. K. ; Hsu, R. B. ; Huang, S. C. ; Ko, W. J. ; Chu, S. H. ; Lin, F. Y. ; Wang, S. S. / Single-Center Experience of Pediatric Heart Transplantation in Taiwan. In: Transplantation Proceedings. 2006 ; Vol. 38, No. 7. pp. 2130-2131.
@article{04c6735f3e2a44688b5b2fa9c89b5ed7,
title = "Single-Center Experience of Pediatric Heart Transplantation in Taiwan",
abstract = "Heart transplantation (HTx) is a treatment for end-stage heart failure or a complex or inoperable congenital defect. The long-term survival and the adequate donor to recipient body weight (D/R BW) ratio remain to be determined. From March 1995 to May 2004, 14 children (6 months-16 years of age) underwent HTx due to underlying diseases of idiopathic dilated cardiomyopathy (n = 10; 71.4{\%}), congenital heart disease (n = 3; 21.4{\%}), and Kawasaki disease (n = 1; 7.1{\%}). Donor-recipient body weight ratio ranged from 0.89 to 3.9. Big heart syndrome was present in one patient when D/R BW ratio was more than 3. Actuarial survival was 92.9{\%} at 5 years after transplantation. Only the one patient who had Kawasaki disease died due to early primary graft failure. HTx is a feasible method with good long-term survival rates for end-stage heart failure or for complex or inoperable congenital defects. After careful pretransplant evaluation, a high D/R BW ratio (more than 3) is acceptable.",
author = "Chou, {N. K.} and Chang, {C. H.} and Chi, {N. H.} and Chang, {C. I.} and Chen, {Y. S.} and Wu, {E. T.} and Wu, {M. H.} and Wang, {J. K.} and Hsu, {R. B.} and Huang, {S. C.} and Ko, {W. J.} and Chu, {S. H.} and Lin, {F. Y.} and Wang, {S. S.}",
year = "2006",
month = "9",
doi = "10.1016/j.transproceed.2006.07.020",
language = "English",
volume = "38",
pages = "2130--2131",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "7",

}

TY - JOUR

T1 - Single-Center Experience of Pediatric Heart Transplantation in Taiwan

AU - Chou, N. K.

AU - Chang, C. H.

AU - Chi, N. H.

AU - Chang, C. I.

AU - Chen, Y. S.

AU - Wu, E. T.

AU - Wu, M. H.

AU - Wang, J. K.

AU - Hsu, R. B.

AU - Huang, S. C.

AU - Ko, W. J.

AU - Chu, S. H.

AU - Lin, F. Y.

AU - Wang, S. S.

PY - 2006/9

Y1 - 2006/9

N2 - Heart transplantation (HTx) is a treatment for end-stage heart failure or a complex or inoperable congenital defect. The long-term survival and the adequate donor to recipient body weight (D/R BW) ratio remain to be determined. From March 1995 to May 2004, 14 children (6 months-16 years of age) underwent HTx due to underlying diseases of idiopathic dilated cardiomyopathy (n = 10; 71.4%), congenital heart disease (n = 3; 21.4%), and Kawasaki disease (n = 1; 7.1%). Donor-recipient body weight ratio ranged from 0.89 to 3.9. Big heart syndrome was present in one patient when D/R BW ratio was more than 3. Actuarial survival was 92.9% at 5 years after transplantation. Only the one patient who had Kawasaki disease died due to early primary graft failure. HTx is a feasible method with good long-term survival rates for end-stage heart failure or for complex or inoperable congenital defects. After careful pretransplant evaluation, a high D/R BW ratio (more than 3) is acceptable.

AB - Heart transplantation (HTx) is a treatment for end-stage heart failure or a complex or inoperable congenital defect. The long-term survival and the adequate donor to recipient body weight (D/R BW) ratio remain to be determined. From March 1995 to May 2004, 14 children (6 months-16 years of age) underwent HTx due to underlying diseases of idiopathic dilated cardiomyopathy (n = 10; 71.4%), congenital heart disease (n = 3; 21.4%), and Kawasaki disease (n = 1; 7.1%). Donor-recipient body weight ratio ranged from 0.89 to 3.9. Big heart syndrome was present in one patient when D/R BW ratio was more than 3. Actuarial survival was 92.9% at 5 years after transplantation. Only the one patient who had Kawasaki disease died due to early primary graft failure. HTx is a feasible method with good long-term survival rates for end-stage heart failure or for complex or inoperable congenital defects. After careful pretransplant evaluation, a high D/R BW ratio (more than 3) is acceptable.

UR - http://www.scopus.com/inward/record.url?scp=33846081497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846081497&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2006.07.020

DO - 10.1016/j.transproceed.2006.07.020

M3 - Article

VL - 38

SP - 2130

EP - 2131

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 7

ER -